NASDAQ

Olema Pharmaceuticals, Inc. (OLMA)

♥ 425 Thanks from members

Live price chart, market sentiment, and community perspectives for Olema Pharmaceuticals, Inc. (NASDAQ: OLMA).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Sean BohenFounder: Garret HamptonLeadership: Sean Bohen (Chief Executive Officer)Leadership: Nick Glover (Chief Financial Officer)Holder: Bain Capital Life SciencesHolder: Fidelity Management and ResearchHolder: Perceptive AdvisorsPalazestrant (OP-1250)Oral Estrogen Receptor Degraders#Olema Pharmaceuticals#OLMA stock#biotech cancer treatment#estrogen receptor degrader#oncology pipeline